New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e
Oncology March 30,2024
Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e
Oncology March 30,2024
Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina
Oncology March 30,2024
Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina
Oncology March 30,2024
Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen
Oncology March 30,2024
Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies

by European Organisation for Research and Treatment of CancerProfessor Laura van 't Veer presented latest results from the I-SPY2 phase 2 clinical trial at the 14th European Breast Cancer Conferen
Oncology March 30,2024
Bacteria subtype linked to growth in up to 50% of human colorectal cancers, researchers report

Bacteria subtype linked to growth in up to 50% of human colorectal cancers, researchers report

byFred Hutchinson Cancer CenterA microscope image shows a human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color. The bacterium is commonly found in people'
Oncology March 30,2024
Bacteria subtype linked to growth in up to 50% of human colorectal cancers, researchers report

Bacteria subtype linked to growth in up to 50% of human colorectal cancers, researchers report

byFred Hutchinson Cancer CenterA microscope image shows a human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color. The bacterium is commonly found in people'
Oncology March 30,2024
Scientists find core regulatory circuit controlling identity of aggressive leukemia

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee
Oncology March 30,2024
Scientists find core regulatory circuit controlling identity of aggressive leukemia

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee
Oncology March 30,2024
An oncologist explains why some cancer patients receive both chemotherapy and surgery

An oncologist explains why some cancer patients receive both chemotherapy and surgery

by Alexander Olawaiye,The ConversationCredit: Pixabay/CC0 Public DomainWhen Kate Middleton, the princess of Wales,announced in March 2024that she was receiving "preventive chemo
Oncology March 30,2024
An oncologist explains why some cancer patients receive both chemotherapy and surgery

An oncologist explains why some cancer patients receive both chemotherapy and surgery

by Alexander Olawaiye,The ConversationCredit: Pixabay/CC0 Public DomainWhen Kate Middleton, the princess of Wales,announced in March 2024that she was receiving "preventive chemo
Oncology March 30,2024
Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

byUTSouthwestern Medical CenterThis illustration depicts a nanoparticle (purple) activating the stimulator of interferon genes (STING) proteins (yellow) in dendritic cells to recruit cytot
Oncology March 30,2024
Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

Activating a specific pathway in a subset of immune cells eradicates immunologically 'cold' tumors, study shows

byUTSouthwestern Medical CenterThis illustration depicts a nanoparticle (purple) activating the stimulator of interferon genes (STING) proteins (yellow) in dendritic cells to recruit cytot
Oncology March 30,2024
Newly discovered link between FBXW7 mutations and EGFR signaling in colorectal cancer

Newly discovered link between FBXW7 mutations and EGFR signaling in colorectal cancer

by Hubrecht InstituteTwo microscopy images of human colon organoids. The left image shows an organoid with the FBXW7 mutation (colorectal cancer), and the right image shows an organoid without th
Oncology March 30,2024
Newly discovered link between FBXW7 mutations and EGFR signaling in colorectal cancer

Newly discovered link between FBXW7 mutations and EGFR signaling in colorectal cancer

by Hubrecht InstituteTwo microscopy images of human colon organoids. The left image shows an organoid with the FBXW7 mutation (colorectal cancer), and the right image shows an organoid without th
Oncology March 30,2024
Biomarker test could improve diagnosis of endometrial cancer

Biomarker test could improve diagnosis of endometrial cancer

by Mike Addelman,University of Manchester(a) Box plots showing the permutation importance of the plasma proteins confirmed by the Boruta algorithm to be important. (b) Crude cumulative AUC analy
Oncology March 30,2024
Biomarker test could improve diagnosis of endometrial cancer

Biomarker test could improve diagnosis of endometrial cancer

by Mike Addelman,University of Manchester(a) Box plots showing the permutation importance of the plasma proteins confirmed by the Boruta algorithm to be important. (b) Crude cumulative AUC analy
Oncology March 30,2024
Social media can boost melanoma detection, research suggests

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key
Oncology March 30,2024
Social media can boost melanoma detection, research suggests

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key
Oncology March 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com